Kshitij Jagtap
YOU?
Author Swipe
View article: Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset Open
Objectives To comprehensively compare the disease burden among patients with RA, PsA and AS using Patient-Reported Outcome Measurement Information System (PROMIS) scores and to identify distinct patient clusters based on comorbidity profil…
View article: Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study Open
Objectives Physical function in RA is largely influenced by multiple clinical factors, however, there is a growing body of evidence that psychological state and other comorbidities also play an essential role. Using data obtained in the CO…
View article: Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study Open
Objectives The objective of this study was to explore the prevalence, characteristics and risk factors of COVID-19 breakthrough infections (BIs) in idiopathic inflammatory myopathies (IIMs) using data from the COVID-19 Vaccination in Autoi…
View article: Flares of autoimmune rheumatic disease following <scp>COVID</scp>‐19 infection: Observations from the <scp>COVAD</scp> study
Flares of autoimmune rheumatic disease following <span>COVID</span>‐19 infection: Observations from the <span>COVAD</span> study Open
The datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request. Supplementary File S1: Please note: The publisher is not responsible for th…
View article: Epidemic Diseases Forestall Module using Data Science and SIR Algorithms
Epidemic Diseases Forestall Module using Data Science and SIR Algorithms Open
This survey paper is intended to prevent epidemic diseases and pandemic diseases. According to the WHO every year in the world over 17 million people die due to this type of disease. Epidemic diseases have lower transmission rate than pand…
View article: Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey Open
This study aimed to assess the incidence, predictors, and outcomes of breakthrough infection (BI) following coronavirus disease (COVID-19) vaccination in patients with systemic sclerosis (SSc), a risk group associated with an immune-suppre…
View article: UNMET NEED IN GERIATRICS – PATIENT VOICE
UNMET NEED IN GERIATRICS – PATIENT VOICE Open
Rapid advancements in patient-care facilities are steadily increasing the global elderly population. Despite this demographic shift, the elderly population continues to be poorly represented in research studies. This report explores the po…
View article: COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study Open
Objectives We investigated coronavirus disease 2019 (COVID-19) vaccine safety in pregnant and breastfeeding women with autoimmune diseases (AID) in the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study. Methods Delayed-onset (>7…
View article: LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study
LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study Open
Background Although many studies have been conducted within COVID-19, there are still unanswered questions regarding breakthrough infections (BTIs), particularly in patients with systemic lupus erythematosus (SLE). We aimed to determine th…
View article: Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study Open
View article: POS1254 REDUCED HEALTH-RELATED QUALITY OF LIFE USING PROMIS IN PATIENTS WITH SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL ANALYSIS FROM THE INTERNATIONAL COVAD-2 E-SURVEY
POS1254 REDUCED HEALTH-RELATED QUALITY OF LIFE USING PROMIS IN PATIENTS WITH SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL ANALYSIS FROM THE INTERNATIONAL COVAD-2 E-SURVEY Open
View article: POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY
POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY Open
View article: POS0558 FLARES OF AUTOIMMUNE RHEUMATIC DISEASE FOLLOWING COVID-19 INFECTION: OBSERVATIONS FROM THE COVAD STUDY
POS0558 FLARES OF AUTOIMMUNE RHEUMATIC DISEASE FOLLOWING COVID-19 INFECTION: OBSERVATIONS FROM THE COVAD STUDY Open
View article: POS1216 MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: DATA FROM A LARGE, GLOBAL E-SURVEY (COVAD STUDY)
POS1216 MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: DATA FROM A LARGE, GLOBAL E-SURVEY (COVAD STUDY) Open
View article: POS0549 BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY
POS0549 BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY Open
View article: POS0573 COMORBIDITIES, COMPLEX MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES AMONGAUTOIMMUNE RHEUMATIC DISEASES: DATA FROM THE COVAD STUDY
POS0573 COMORBIDITIES, COMPLEX MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES AMONGAUTOIMMUNE RHEUMATIC DISEASES: DATA FROM THE COVAD STUDY Open
View article: LB0006 COVID-19 severity, breakthrough infections and anti-SARS-CoV-2 vaccine safety in young people with rheumatic and non-rheumatic autoimmune diseases: results from the COVAD1 and COVAD2 projects
LB0006 COVID-19 severity, breakthrough infections and anti-SARS-CoV-2 vaccine safety in young people with rheumatic and non-rheumatic autoimmune diseases: results from the COVAD1 and COVAD2 projects Open
Background Notwithstanding the wealth of literature on COVID-19, studies focusing on young people with autoimmune diseases (ADs) are lacking. Despite their younger age, they may have been exposed to immunosuppressants (IS) for longer than …
View article: POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY
POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY Open
Background Systemic lupus erythematosus (SLE) can result in impaired daily physical function through various mechanisms including active disease, chronic damage, and mental health symptoms that are common in the disease. However, the key d…
View article: AB1312 MYOSITIS PATIENTS WITHOUT AUTOIMMUNE MULTIMORBIDITY AT LOWER RISK OF DELAYED ONSET COVID-19 VACCINE ADVERSE EVENTS THAN OTHER AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY
AB1312 MYOSITIS PATIENTS WITHOUT AUTOIMMUNE MULTIMORBIDITY AT LOWER RISK OF DELAYED ONSET COVID-19 VACCINE ADVERSE EVENTS THAN OTHER AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY Open
Background Limited data on the delayed onset effects of COVID-19 vaccination in patients with idiopathic inflammatory myopathies (IIMs) continues to be a significant cause of hesitancy in this vulnerable group. Objectives To analyze the de…
View article: Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys Open
Objectives Disease flares in the post–coronavirus disease 2019 (COVID-19) vaccination period represent a prominent concern, though risk factors are poorly understood. We studied these flares among patients with idiopathic inflammatory myop…
View article: Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study Open
View article: OA29 Flares following COVID-19 vaccination in patients with idiopathic inflammatory myopathies: combined analysis from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) studies
OA29 Flares following COVID-19 vaccination in patients with idiopathic inflammatory myopathies: combined analysis from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) studies Open
Background/Aims Flares following COVID-19 vaccination are an emerging concern among patients with rare rheumatic disease like idiopathic inflammatory myositis (IIMs), whereas data and understanding of this is rather limited. We aimed to st…
View article: P065 Post COVID-19 Syndrome in patients with autoimmune rheumatic diseases: Results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
P065 Post COVID-19 Syndrome in patients with autoimmune rheumatic diseases: Results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study Open
Background/Aims Post COVID-19 syndrome (PCS) is an emerging cause of morbidity and poor quality of life in COVID-19 survivors. We aimed to assess the prevalence, risk factors, outcomes, and association with disease flares of PCS in patient…
View article: Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey Open
View article: Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys Open
Objective Flares of autoimmune rheumatic diseases (AIRDs) following COVID-19 vaccination are a particular concern in vaccine-hesitant individuals. Therefore, we investigated the incidence, predictors and patterns of flares following vaccin…
View article: Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis
Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis Open
View article: Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys Open
Objective COVID-19 vaccines have a favorable safety profile in patients with autoimmune rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however, hesitancy continues to persist among these patients. Therefore, …
View article: COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies Open
Journal Article COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies Get access Laura Andreoli, Laura Andreoli Rheumatology and Clinical Immunology Unit, Azienda Socio-Sanitaria Territoriale …
View article: COVAD survey 2 long-term outcomes: unmet need and protocol
COVAD survey 2 long-term outcomes: unmet need and protocol Open
Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, …
View article: INFLAMMAGING IN MUSCLE: THE MISSING LINK BETWEEN SARCOPENIA AND IDIOPATHIC INFLAMMATORY MYOPATHIES
INFLAMMAGING IN MUSCLE: THE MISSING LINK BETWEEN SARCOPENIA AND IDIOPATHIC INFLAMMATORY MYOPATHIES Open
Ageing is associated with a progressive decline in muscle mass and quality. Inflammaging, chronic low-grade inflammation is a major causative as well as maintenance factor in age-related disorders. Idiopathic inflammatory myopathies or myo…